Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (CAT#: TAB-894)
Recombinant human monoclonal antibody expressed in CHO binding to human cytomegalovirus glycoprotein B. Regavirumab is a human monoclonal antibody against cytomegalovirus infections.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in SDS-PAGE
SDS-PAGE analysis of TAB-894 in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Figure 2 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in HPLC
HPLC analysis of TAB-894 shows the purity is>95%.
Figure 3 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in ELISA
ELISA analysis of TAB-894 was performed by coating with Human cytomegalovirus (HCMV) Glycoprotein B.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
Figure 4 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in WB
Western blot analysis of TAB-894 was performed with Human cytomegalovirus (HCMV) Glycoprotein B.
TAB-894 incubation concentration: 2ng/μL.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
Lane 1: Reducing Antigen (0.1μg)
Lane 2: Reducing Antigen (0.3μg)
Lane 3: Reducing Antigen (0.6μg)
Figure 5 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in DB
Dot Blot analysis of TAB-894 was performed by coating with Human cytomegalovirus (HCMV) Glycoprotein B.
TAB-894 incubation concentration: 2ng/μL.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
NC: Negative control PC: Positive control
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- IgG1 - kappa
- Species Reactivity
- HHV-5
- Applications
- Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
- CAS
- 153101-26-9
- Generic Name
- Regavirumab
- Related Disease
- Cytomegalovirus (CMV) infections
Product Property
- Purity
- >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- Regavirumab;153101-26-9;Tl-23;MCA C23;Group I (dsDNA);Herpesviridae;Betaherpesvirinae;Cytomegalovirus;CMV;CMV glycoprotein B;CMV glycoprotein GP55;Cytomegalovirus glycoprotein GP55;gB;Glycoprotein B;Glycoprotein GP55;HCMV;HCMV glycoprotein B;HCMV glycopro
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Regavirumab"
Afuco™ Anti-HCMV ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-894)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human cytomegalovirus glycoprotein B. It is a human monoclonal antibody against cytomegalovirus infections.
See other products for "HCMV"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1186-VHH | Recombinant Anti-HCMV VHH Single Domain Antibody | IHC, ICC, IP, ChiP, Neut | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-894. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA, IP, WB, IHC, IF, FuncS
Application: FuncS, Inhib, IP, ELISA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: ELISA, Inhib, FuncS
Application: ELISA, WB
Application: WB, ELISA, FuncS
Application: IB, FC, ELISA, FuncS
Application: ELISA, FuncS, RIA, IP, IF, IHC, IA, Block
For Research Use Only. Not For Clinical Use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.